Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Diamant

Showing results (21-30 of 212) with videos related to

Pageof 22
Sort By:
Journal of Diabetes and Its Complications|June 26, 2012
Vesiculopustular dermatosis: an uncommon side-effect of liraglutide?Femke Besemer, Arjan J Verschoor, Michaela Diamant, et al.
Atherosclerosis|March 28, 2009
Differential effects of cross-sex hormonal treatment on plasma asymmetric dimethylarginine (ADMA) in healthy male-to-female and female-to-male transsexualsMathijs C Bunck, Erik J Giltay, Michaela Diamant, et al.
Diabetes Care|October 27, 2005
No independent association of alanine aminotransferase with risk of future type 2 diabetes in the Hoorn studyRoger K Schindhelm, Jacqueline M Dekker, Giel Nijpels, et al.
Diabetes & Vascular Disease Research|October 30, 2008
Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart diseaseHelene von Bibra, Michaela Diamant, Peter G Scheffer, et al.
Lancet (London, England)|July 9, 2010
Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trialMichaela Diamant, Luc Van Gaal, Stephen Stranks, et al.
The Lancet. Diabetes & Endocrinology|August 16, 2014
Combining incretin-based drugs and RAAS inhibitors: more cons than pros?Lennart Tonneijck, Marcel H A Muskiet, Mark M Smits, et al.
Diabetes/Metabolism Research and Reviews|July 13, 2006
Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular diseaseRoger K Schindhelm, Michaela Diamant, Jacqueline M Dekker, et al.
Circulation|November 6, 2002
Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitusMichaela Diamant, Rienk Nieuwland, Renée F Pablo, et al.
BMJ Case Reports|August 11, 2011
Autonomous prolactin secretion in two male-to-female transgender patients using conventional oestrogen dosagesMathijs C Bunck, Miguel Debono, Erik J Giltay, et al.
European Journal of Endocrinology|June 28, 2008
Lack of association of liver fat with model parameters of beta-cell function in men with impaired glucose tolerance and type 2 diabetesMaarten E Tushuizen, Mathijs C Bunck, Petra J W Pouwels, et al.
Pageof 22

Showing results (21-30 of 212) with videos related to

Sort By:
Pageof 22
Journal of Diabetes and Its Complications|June 26, 2012
Vesiculopustular dermatosis: an uncommon side-effect of liraglutide?Femke Besemer, Arjan J Verschoor, Michaela Diamant, et al.
Atherosclerosis|March 28, 2009
Differential effects of cross-sex hormonal treatment on plasma asymmetric dimethylarginine (ADMA) in healthy male-to-female and female-to-male transsexualsMathijs C Bunck, Erik J Giltay, Michaela Diamant, et al.
Diabetes Care|October 27, 2005
No independent association of alanine aminotransferase with risk of future type 2 diabetes in the Hoorn studyRoger K Schindhelm, Jacqueline M Dekker, Giel Nijpels, et al.
Diabetes & Vascular Disease Research|October 30, 2008
Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart diseaseHelene von Bibra, Michaela Diamant, Peter G Scheffer, et al.
Lancet (London, England)|July 9, 2010
Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trialMichaela Diamant, Luc Van Gaal, Stephen Stranks, et al.
The Lancet. Diabetes & Endocrinology|August 16, 2014
Combining incretin-based drugs and RAAS inhibitors: more cons than pros?Lennart Tonneijck, Marcel H A Muskiet, Mark M Smits, et al.
Diabetes/Metabolism Research and Reviews|July 13, 2006
Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular diseaseRoger K Schindhelm, Michaela Diamant, Jacqueline M Dekker, et al.
Circulation|November 6, 2002
Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitusMichaela Diamant, Rienk Nieuwland, Renée F Pablo, et al.
BMJ Case Reports|August 11, 2011
Autonomous prolactin secretion in two male-to-female transgender patients using conventional oestrogen dosagesMathijs C Bunck, Miguel Debono, Erik J Giltay, et al.
European Journal of Endocrinology|June 28, 2008
Lack of association of liver fat with model parameters of beta-cell function in men with impaired glucose tolerance and type 2 diabetesMaarten E Tushuizen, Mathijs C Bunck, Petra J W Pouwels, et al.
Pageof 22